Futures
Hundreds of contracts settled in USDT or BTC
TradFi
Gold
Trade global traditional assets with USDT in one place
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Participate in events to win generous rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and enjoy airdrop rewards!
Futures Points
Earn futures points and claim airdrop rewards
Investment
Simple Earn
Earn interests with idle tokens
Auto-Invest
Auto-invest on a regular basis
Dual Investment
Buy low and sell high to take profits from price fluctuations
Soft Staking
Earn rewards with flexible staking
Crypto Loan
0 Fees
Pledge one crypto to borrow another
Lending Center
One-stop lending hub
VIP Wealth Hub
Customized wealth management empowers your assets growth
Private Wealth Management
Customized asset management to grow your digital assets
Quant Fund
Top asset management team helps you profit without hassle
Staking
Stake cryptos to earn in PoS products
Smart Leverage
New
No forced liquidation before maturity, worry-free leveraged gains
GUSD Minting
Use USDT/USDC to mint GUSD for treasury-level yields
Why Is Impact BioMedical Stock (IBO) Up Today?
Impact BioMedical IBO +0.80% ▲ stock underwent a massive rally on Thursday after the specialty biopharmaceuticals and consumer healthcare company revealed an update to its merger agreement with Dr Ashleys Limited. The deal also included agreements with PubCo, the parent company of Dr Ashleys Limited, Dr Ashleys Bio Labs Limited, and Kanans Visvanats.
Claim 50% Off TipRanks Premium
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential
This change included an addition to the number of shares that will be issued by PubCo as part of the merger agreement. In addition to the 22,000 shares that will be issued to Impact BioMedical CEO Frank Heuszel, PubCo will issue 53,000 and 75,000 shares to DSS, Inc., DSS -0.20% ▼ across two batches. DSS, Inc., is a large shareholder of IBO stock, with nearly 93 million shares held between it and DSS BioHealth Security, Inc., representing an 88.87% stake in Impact BioMedical.
Impact BioMedical also amended the merger completion date to take into account the new changes. The companies now have until July 1, 2026, to complete the merger, compared to the previous deadline of March 31, 2026.
Impact BioMedical Stock Movement Today
Impact BioMedical stock was up 82.72% in pre-market trading on Thursday, following a slight rally yesterday. The shares have fallen 18.16% year-to-date and 65.84% over the past 12 months.
With today’s news came heavy trading of Impact BioMedical, as some 46 million shares changed hands, compared to a three-month daily average trading volume of about 174,000 shares.
Is Impact BioMedical Stock a Buy, Sell, or Hold?
Analyst coverage of Impact BioMedical is lacking. Instead, traders can look to TipRanks’ Technical Analysis tool to get a better understanding of the stock. The Overall Consensus for IBO is Strong Sell, based on 14 Bearish, six Neutral, and two Bullish indicators.
Disclaimer & DisclosureReport an Issue